Evidence map›Paper›PMID 39685999›Full record

ArticleSensors (Basel, Switzerland)2024

LOTUS Software to Process Wearable EmbracePlus Data.

Jack S Fogarty

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jack S FogartyScience of Learning in Education Centre, National Institute of Education, Nanyang Technological University, Singapore 637616, Singapore.ORCID 0000-0001-6210-1067

Funding

Ministry of Education OER 26/22 JFMinistry of Education RI 8/22 AMG
6 · The paper itself

Abstract

The Empatica EmbracePlus is a recent innovation in medical-grade wristband wearable sensors that enable unobtrusive continuous measurement of pulse rate, electrodermal activity, skin temperature, and various accelerometry-based actigraphy measures using a minimalistic smartwatch design. The advantage of this lightweight wearable is the potential for holistic longitudinal recording and monitoring of physiological processes that index a suite of autonomic functions, as well as to provide ecologically valid insights into human behaviour, health, physical activity, and psychophysiological processes. Given the longitudinal nature of wearable recordings, EmbracePlus data collection is managed by storing raw timeseries in short 'chunks' in avro file format organised by universal standard time. This is memory-efficient but requires programming expertise to compile the raw data into continuous file formats that can be processed using standard techniques. Currently, there are no accessible tools available to compile and analyse raw EmbracePlus data over user-defined time periods. To address that, we introduce the LOTUS toolkit, an open-source graphical user interface that allows users to reconstitute and process EmbracePlus datasets over select time intervals. LOTUS is available on GitHub, and currently allows users to compile raw EmbracePlus data into unified timeseries stored in more familiar Excel or Matlab file formats to facilitate signal processing and analysis. Future work will expand the toolkit to process Empatica E4 and other wearable signal data, while also integrating more sophisticated functions for feature extraction and analysis.

Indexed as

SoftwareWearable Electronic DevicesAccelerometryActigraphyHeart RateHumansMonitoring, PhysiologicSignal Processing, Computer-AssistedSkin TemperatureEmbracePlusEmpaticaphysiological signal processingsoftwarewearables

Identifiers

PMID39685999
PMCPMC11644628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.